Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
about
To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke RodentsCurrent evidence for AMPK activation involvement on resveratrol-induced neuroprotection in cerebral ischemia.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.Metformin Alleviated the Neuronal Oxidative Stress in Hippocampus of Rats under Single Prolonged Stress.Metformin Attenuates Neurological Deficit after Intracerebral Hemorrhage by Inhibiting Apoptosis, Oxidative Stress and Neuroinflammation in Rats.Pre-Treatment with Metformin in Comparison with Post-Treatment Reduces Cerebral Ischemia Reperfusion Induced Injuries in Rats.
P2860
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@en
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@nl
type
label
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@en
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@nl
prefLabel
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@en
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@nl
P2093
P2860
P1476
Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction.
@en
P2093
Li-San Zhang
Wei-Wei Hou
Wei-Wei Hu
Xiang-Nan Zhang
Xiao-Li Wu
Yan-Rong Zheng
P2860
P2888
P304
P356
10.1007/S11064-016-1988-8
P577
2016-06-27T00:00:00Z